This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Suzhou Sinovent Pharmaceuticals Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Shiqun Wang
Introduction
Shiqun Wang is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of targeted cancer therapies. His work focuses on innovative solutions that have the potential to transform treatment options for patients.
Latest Patents
Shiqun Wang holds a patent for a five-membered heterocyclic amide WNT pathway inhibitor. This compound exhibits remarkable anti-tumor activity and is based on target-based rational drug design. The inhibitor has considerable clinical application value and market potential, making it a significant advancement in cancer treatment.
Career Highlights
Wang is associated with Suzhou Sinovent Pharmaceuticals Co., Ltd., where he continues to contribute to pharmaceutical innovations. His expertise in drug design and development has positioned him as a key figure in the industry.
Collaborations
He has worked alongside talented colleagues such as Yonghui Wang and Yan Zhu, contributing to a collaborative environment that fosters innovation and progress in pharmaceutical research.
Conclusion
Shiqun Wang's contributions to the field of pharmaceuticals, particularly through his patented WNT pathway inhibitor, highlight his role as an influential inventor. His work not only advances cancer treatment but also showcases the potential of innovative drug design in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile